MRI Assessment of Treatment Response in HIV‐associated NAFLD: A Randomized Trial of a Stearoyl‐Coenzyme‐A‐Desaturase‐1 Inhibitor (ARRIVE Trial)-Reference-Cited by-同舟云学术

MRI Assessment of Treatment Response in HIV‐associated NAFLD: A Randomized Trial of a Stearoyl‐Coenzyme‐A‐Desaturase‐1 Inhibitor (ARRIVE Trial)

Published:2019-06-18 Issue:5 Volume:70 Page:1531-1545
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Ajmera Veeral H.¹²^ORCID,Cachay Edward³,Ramers Christian⁴,Vodkin Irine²,Bassirian Shirin¹,Singh Seema¹,Mangla Neeraj¹,Bettencourt Richele¹,Aldous Jeannette L.⁵,Park Daniel⁵,Lee Daniel³^ORCID,Blanchard Jennifer³,Mamidipalli Adrija⁶,Boehringer Andrew⁶,Aslam Saima⁷,Leinhard Olof Dahlqvist⁸⁹,Richards Lisa¹,Sirlin Claude⁶,Loomba Rohit¹²¹⁰

Affiliation:

1. NAFLD Research CenterUniversity of California San Diego Health La Jolla CA

2. Division of Gastroenterology, Department of MedicineUniversity of California San Diego Health La Jolla CA

3. Division of Infectious DiseasesOwen Clinic, University of California San Diego San Diego CA

4. Family Health Center San Diego CA

5. San Ysidro Health San Diego CA

6. Liver Imaging GroupUniversity of California San Diego La Jolla CA

7. Division of Infectious Diseases and Global Public HealthUniversity of California San Diego San Diego CA

8. AMRA Medical AB Linköping Sweden

9. Department of Medical and Health SciencesLinköping University Linköping Sweden

10. Division of Epidemiology, Department of Family and Preventive MedicineUniversity of California San Diego La Jolla CA

Funder

Atlantic Philanthropies

John A. Hartford Foundation

American Association for the Study of Liver Diseases

Publisher

Wiley

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.30674

Reference46 articles.

1. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

2. The global NAFLD epidemic

4. Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection

5. Clinical, biochemical and histological differences between HIV-associated NAFLD and primary NAFLD: a case-control study

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and experimental pharmacotherapy for the management of non-alcoholic fatty liver disease;Hormones;2024-08-07

2. Interoperator reproducibility of quantitative ultrasound analysis of hepatic steatosis in participants with suspected MASLD: A prospective study;European Journal of Radiology;2024-06

3. Advances in management of metabolic dysfunction-associated steatotic liver disease: from mechanisms to therapeutics;Lipids in Health and Disease;2024-04-02

4. Fatty Liver Disease: Enter the Metabolic Era;Current HIV/AIDS Reports;2023-10-26

5. Prevalence and Characteristics of Nonalcoholic Fatty Liver Disease and Fibrosis in People Living With HIV Monoinfection: A Systematic Review and Meta-analysis;Clinical Gastroenterology and Hepatology;2023-07